Skip to content

News & calendar

news: as of 2026-10-07
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-13

Tue · 13 Oct · today

Wed · 14 Oct

Behind

published · newest first

Fri · 10 Jul

partnership

08:43
Google News: Hanwha Solutions (Qcells)

Hanwha Qcells wins contract for the largest renewable energy complex in the U.S.

Hanwha Qcells won a contract for the largest renewable energy complex in the United States.

Markets open original ↗

partnership

08:09
Google News: Rheinmetall AG

Major order: Kuwait procures Rheinmetall's MASS decoy launchers for the first time

Kuwait placed its first order for Rheinmetall's MASS decoy launchers.

Markets open original ↗

earnings

07:42
Google News: ICON plc

Icon reiterates 2026 guidance of $7.85B-$8.15B revenue and $10-$11 EPS amid 1.42x net book-to-bill

Icon reiterated its 2026 guidance of $7.85B-$8.15B revenue and $10-$11 EPS.

Markets open original ↗

product

07:30
Google News: Revolution Medicines, Inc.

Revolution Medicines' pancreatic cancer pill doubles survival, cuts death risk 60% in trial

Revolution Medicines' pancreatic cancer pill doubled survival and cut death risk by 60% in a clinical trial.

Markets open original ↗

regulation

07:00
Google News: Alignment Healthcare, Inc.

Alignment Healthcare (ALHC) Governance Under Scrutiny After Whistleblower Lawsuit and Upcoming Q2 Earnings Call

Alignment Healthcare's governance came under scrutiny following a whistleblower lawsuit ahead of its Q2 earnings call.

Markets open original ↗

The wire

everything that arrived · 7 days